Francesca Finetti

Dr. Francesca Finetti

Department of Life Sciences, University of Siena, Siena, Italy
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2009 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
FFFrancesca Finetti
Francesca Finetti
SPSilvia Rossi Paccani
Silvia Rossi Paccani
MRMaria Giovanna Riparbelli
Maria Giovanna Riparbelli
EGEmiliana Giacomello
Emiliana Giacomello
GPGiuseppe Perinetti
Giuseppe Perinetti
CBCosima T. Baldari
Cosima T. Baldari

13 July 2009 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
TTT Tiepolo
T Tiepolo
AAA Angelin
A Angelin
EPE Palma
E Palma
PSPatrizia Sabatelli
Patrizia Sabatelli
LMLuciano Merlini
Luciano Merlini
Paolo BernardiPaolo Bernardi
Paolo Bernardi
Background and purpose: We have investigated the therapeutic effects of the selective cyclophilin inhibitor D‐MeAla3‐EtVal4‐cyclosporin (Debio 025) in myopathicCol6a1−/−mice, a model of muscular dystrophies due to defects of collagen VI.Experimental approach: We studied calcineurin activity based on NFAT translocation; T cell activation based on expression of CD69 and CD25; propensity to open the permeability transition pore in mitochondria and skeletal muscle fibres based on the ability to retain Ca2+and on membrane potential, respectively; muscle ultrastructure by electronmicroscopy; and apoptotic rates by terminal deoxynucleotidyl transferase‐mediated dUTP nick end labelling assays inCol6a1−/−mice before after treatment with Debio 025.Key results: Debio 025 did not inhibit calcineurin activity, yet it desensitizes the mitochondrial permeability transition porein vivo. Treatment with Debio 025 prevented the mitochondrial dysfunction and normalized the apoptotic rates and ultrastructural lesions of myopathicCol6a1−/−mice.Conclusions and implications: Desensitization of the mitochondrial permeability transition pore can be achieved by selective inhibition of matrix cyclophilin D without inhibition of calcineurin, resulting in an effective therapy ofCol6a1−/−myopathic mice. These findings provide an important proof of principle that collagen VI muscular dystrophies can be treated with Debio 025. They represent an essential step towards an effective therapy for Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy, because Debio 025 does not expose patients to the potentially harmful effects of immunosuppression.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
FFFrancesca Finetti
Francesca Finetti
Laura PatrussiLaura Patrussi
Laura Patrussi
GMGiulia Masi
Giulia Masi
AOAnna Onnis
Anna Onnis
DGDonatella Galgano
Donatella Galgano
CBCosima T. Baldari
Cosima T. Baldari
T cell activation requires sustained signaling at the immune synapse, a specialized interface with the antigen-presenting cell (APC) that assembles following T cell antigen receptor (TCR) engagement by major histocompatibility complex (MHC)-bound peptide. Central to sustained signaling is the continuous recruitment of TCRs to the immune synapse. These TCRs are partly mobilized from an endosomal pool by polarized recycling. We have identified IFT20, a component of the intraflagellar transport (IFT) system that controls ciliogenesis, as a central regulator of TCR recycling to the immune synapse. Here, we have investigated the interplay of IFT20 with the Rab GTPase network that controls recycling. We found that IFT20 forms a complex with Rab5 and the TCR on early endosomes. IFT20 knockdown (IFT20KD) resulted in a block in the recycling pathway, leading to a build-up of recycling TCRs in Rab5+ endosomes. Recycling of the transferrin receptor (TfR), but not of CXCR4, was disrupted by IFT20 deficiency. The IFT components IFT52 and IFT57 were found to act together with IFT20 to regulate TCR and TfR recycling. The results provide novel insights into the mechanisms that control TCR recycling and immune synapse assembly, and underscore the trafficking-related function of the IFT system beyond ciliogenesis.

13 March 2015 in Cell Death & Differentiation
Verified
Journal Article
Closed access
AOAnna Onnis
Anna Onnis
FFFrancesca Finetti
Francesca Finetti
Laura PatrussiLaura Patrussi
Laura Patrussi
MGM Gottardo
M Gottardo
CCChiara Cassioli
Chiara Cassioli
CBCosima T. Baldari
Cosima T. Baldari

1 October 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
OSOttavia Spiga
Ottavia Spiga
Andrea BerniniAndrea Bernini
Andrea Bernini
ACArianna Ciutti
Arianna Ciutti
SCStefano Chiellini
Stefano Chiellini
NMNicola Menciassi
Nicola Menciassi
NNNeri Niccolai
Neri Niccolai

1 January 2015 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
FFFrancesca Finetti
Francesca Finetti
Laura PatrussiLaura Patrussi
Laura Patrussi
DGDonatella Galgano
Donatella Galgano
CCChiara Cassioli
Chiara Cassioli
GPGiuseppe Perinetti
Giuseppe Perinetti
CBCosima T. Baldari
Cosima T. Baldari
IFT20, a component of the intraflagellar transport (IFT) system that controls ciliogenesis, regulates immune synapse assembly in the non-ciliated T-cell by promoting T-cell receptor (TCR) recycling. Here, we have addressed the role of Rab8 (for which there are two isoforms Rab8a and Rab8b), a small GTPase implicated in ciliogenesis, in TCR traffic to the immune synapse. We show that Rab8, which colocalizes with IFT20 in Rab11+ endosomes, is required for TCR recycling. Interestingly, as opposed to in IFT20-deficient T-cells, TCR+ endosomes polarized normally beneath the immune synapse membrane in the presence of dominant-negative Rab8, but were unable to undergo the final docking or fusion step. This could be accounted for by the inability of the vesicular (v)-SNARE VAMP-3 to cluster at the immune synapse in the absence of functional Rab8, which is responsible for its recruitment. Of note, and similar to in T-cells, VAMP-3 interacts with Rab8 at the base of the cilium in NIH-3T3 cells, where it regulates ciliary growth and targeting of the protein smoothened. The results identify Rab8 as a new player in vesicular traffic to the immune synapse and provide insight into the pathways co-opted by different cell types for immune synapse assembly and ciliogenesis.